Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Pentraxin 3 and other inflammatory biomarkers related to atrial fibrillation in cardiac surgery.

Holubcova Z, Kunes P, Mandak J, Vlaskova D, Kolackova M, Holmannova D, Andrys C, Krejsek J, Holubec T.

Perfusion. 2017 May;32(4):269-278. doi: 10.1177/0267659116679248. Epub 2016 Nov 16.

PMID:
27852958
2.

Effects of conventional CPB and mini-CPB on neutrophils CD162, CD166 and CD195 expression.

Holmannova D, Kolackova M, Mandak J, Kunes P, Holubcova Z, Holubec T, Krejsek J.

Perfusion. 2017 Mar;32(2):141-150. doi: 10.1177/0267659116669586. Epub 2016 Sep 24.

PMID:
27625334
3.

Impact of cardiac surgery on the expression of CD40, CD80, CD86 and HLA-DR on B cells and monocytes.

Holmannova D, Kolackova M, Kunes P, Krejsek J, Mandak J, Andrys C.

Perfusion. 2016 Jul;31(5):391-400. doi: 10.1177/0267659115612905. Epub 2015 Oct 25.

PMID:
26503949
4.

New haemostat in thoracic surgery.

Habal P, Omran N, Kovacicova K, Mandak J.

Bratisl Lek Listy. 2015;116(8):506-8.

PMID:
26350093
5.

Perspective in predicting the effect of pleurodesis in the treatment of malignant pleural effusions.

Habal P, Omran N, Kovacicova K, Chek J, Jankovicova K, Mandak J.

Bratisl Lek Listy. 2015;116(5):285-8.

PMID:
25924636
6.

Effective and rapid sealing of coronary, aortic and atrial suture lines †.

Skorpil J, Paraforos A, Mandak J, Cohn WE, Hajek T, Friedrich I.

Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):720-4; discussion 724. doi: 10.1093/icvts/ivv061. Epub 2015 Mar 24.

PMID:
25810290
7.

New biomarkers in the selection of patients for talcage of pleural cavity in the palliative therapy of malign pleural exudate.

Habal P, Omran N, Chek J, Krejsek J, Mandak J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Dec;159(4):576-81. doi: 10.5507/bp.2015.005. Epub 2015 Feb 10.

8.

Combined surgical treatment of lung cancer and heart diseases.

Kovacicova K, Omran N, Mandak J.

Bratisl Lek Listy. 2014;115(12):776-80.

PMID:
25520227
9.

Actual position of interleukin(IL)-33 in atherosclerosis and heart failure: Great Expectations or En attendant Godot?

Kunes P, Mandak J, Holubcova Z, Kolackova M, Krejsek J.

Perfusion. 2015 Jul;30(5):356-74. doi: 10.1177/0267659114562269. Epub 2014 Dec 11. Review.

PMID:
25501624
10.

Inhibitory CD200R and proapoptotic CD95/CD95L molecules on innate immunity cells are modulated by cardiac surgery.

Holmannova D, Kolackova M, Mandak J, Kunes P, Holubcova Z, Krejsek J, Vlaskova D, Andrys C.

Perfusion. 2015 Oct;30(7):543-55. doi: 10.1177/0267659114558286. Epub 2014 Nov 17.

PMID:
25404054
11.

Could pentraxin 3 be a new diagnostic marker for excessive inflammatory response in cardiac surgery?

Holubcova Z, Kunes P, Mandak J, Kolackova M, Andrys C, Krejsek J, Holubec T.

Thorac Cardiovasc Surg. 2014 Dec;62(8):670-6. doi: 10.1055/s-0034-1384668. Epub 2014 Aug 22.

PMID:
25148605
12.

Predictive value of systemic and local inflammation parameters in talc pleurodesis assessment.

Habal P, Omran N, Jankovicova K, Krejsek J, Mandak J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):234-41. doi: 10.5507/bp.2014.038. Epub 2014 Jul 18.

13.

Penetrating aortic injury.

Omran N, Habal P, Mandak J, Pojar M, Renc O, Harrer J.

Ann Thorac Surg. 2014 Apr;97(4):e119. doi: 10.1016/j.athoracsur.2013.12.076. No abstract available.

PMID:
24694454
14.

Isolated thoracic aortitis.

Omran N, Laco J, Krbal L, Vojacek J, Mandak J.

J Card Surg. 2014 Mar;29(2):225-30. doi: 10.1111/jocs.12268. Epub 2013 Dec 17.

PMID:
24345043
15.

Broncho-pleural fistula following vacuum-assisted closure therapy.

Omran N, Habal P, Mandak J, Chek JL.

J Card Surg. 2013 Jul;28(4):397-8. doi: 10.1111/jocs.12126. Epub 2013 May 27.

PMID:
23711339
16.

The long pentraxin PTX3: a candidate anti-inflammatory mediator in cardiac surgery.

Kunes P, Mandak J, Holubcova Z, Kolackova M, Krejsek J.

Perfusion. 2013 Sep;28(5):377-89. doi: 10.1177/0267659113483799. Epub 2013 Apr 26. Review.

PMID:
23625866
17.

TLR2 in pleural fluid is modulated by talc particles during pleurodesis.

Jankovicova K, Kondelkova K, Habal P, Andrys C, Krejsek J, Mandak J.

Clin Dev Immunol. 2012;2012:158287. doi: 10.1155/2012/158287. Epub 2012 Dec 10.

18.

The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions.

Habal P, Jankovicova K, Omran N, Kondelkova K, Krejsek J, Mandak J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Dec;157(4):311-5. doi: 10.5507/bp.2012.095. Epub 2012 Dec 7.

19.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators.

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

20.

Unusual cause of chest pain: a "souvenir" from the past.

Habal P, Omran N, Mandak J, Vojacek J.

Asian Cardiovasc Thorac Ann. 2012 Oct;20(5):607. doi: 10.1177/0218492311429616. No abstract available.

PMID:
23087313

Supplemental Content

Loading ...
Support Center